Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

75 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Nanomedicine therapeutic approaches to overcome cancer drug resistance.
Markman JL, Rekechenetskiy A, Holler E, Ljubimova JY. Markman JL, et al. Among authors: ljubimova jy. Adv Drug Deliv Rev. 2013 Nov;65(13-14):1866-79. doi: 10.1016/j.addr.2013.09.019. Epub 2013 Oct 10. Adv Drug Deliv Rev. 2013. PMID: 24120656 Free PMC article. Review.
Nanoconjugate based on polymalic acid for tumor targeting.
Ljubimova JY, Fujita M, Khazenzon NM, Lee BS, Wachsmann-Hogiu S, Farkas DL, Black KL, Holler E. Ljubimova JY, et al. Chem Biol Interact. 2008 Jan 30;171(2):195-203. doi: 10.1016/j.cbi.2007.01.015. Epub 2007 Feb 8. Chem Biol Interact. 2008. PMID: 17376417 Free PMC article.
Inhibition of brain tumor growth by intravenous poly (β-L-malic acid) nanobioconjugate with pH-dependent drug release [corrected].
Ding H, Inoue S, Ljubimov AV, Patil R, Portilla-Arias J, Hu J, Konda B, Wawrowsky KA, Fujita M, Karabalin N, Sasaki T, Black KL, Holler E, Ljubimova JY. Ding H, et al. Among authors: ljubimova jy. Proc Natl Acad Sci U S A. 2010 Oct 19;107(42):18143-8. doi: 10.1073/pnas.1003919107. Epub 2010 Oct 4. Proc Natl Acad Sci U S A. 2010. PMID: 20921419 Free PMC article.
Polymalic acid-based nanobiopolymer provides efficient systemic breast cancer treatment by inhibiting both HER2/neu receptor synthesis and activity.
Inoue S, Ding H, Portilla-Arias J, Hu J, Konda B, Fujita M, Espinoza A, Suhane S, Riley M, Gates M, Patil R, Penichet ML, Ljubimov AV, Black KL, Holler E, Ljubimova JY. Inoue S, et al. Among authors: ljubimova jy. Cancer Res. 2011 Feb 15;71(4):1454-64. doi: 10.1158/0008-5472.CAN-10-3093. Epub 2011 Feb 8. Cancer Res. 2011. PMID: 21303974 Free PMC article.
75 results